Niacin has come a long way since its discovery in the 1950s as the first oral agent for treating abnormal blood lipids to prevent cardiovascular disease and death. In the years that followed, unsophisticated formulas and faulty research tarnished its stellar reputation.

Niacin has come a long way since its discovery in the 1950s as the first oral agent for treating abnormal blood lipids to prevent cardiovascular disease and death. In the years that followed, unsophisticated formulas and faulty research tarnished its stellar reputation.

Now, niacin is back, and it’s better than ever, thanks to innovations in tablet delivery and an impressive body of well-controlled clinical studies. In this book, you’ll learn all the details so you’re better prepared to talk with your doctor about how today’s niacin can help you achieve your health goals.

For starters, today’s niacin is the only oral therapy that delivers a broad range of cardioprotective actions, including:

• Best agent to raise “good” HDL cholesterol
• Lowers “bad” LDL cholesterol
• Reduces small, dense LDL particles, the most harmful form
• One of the best agents to lower triglycerides
• Only oral agent to significantly lower lipoprotein (a), the “heart attack cholesterol”
• Increases apoprotein A-I, the main protein associated with protective HDL cholesterol
• Supports healthy blood vessel function

Plus three niacin companions for healthy aging.

Joseph M. Keenan, MD is a physician, researcher and professor emeritus in the Department of Family Medicine and Community Health, University of Minnesota. He is one of the world’s foremost experts on the use of niacin therapy for the treatment of cardiovascular disease and dyslipidemia.

Kathleen M. Dunn, MPH, RD is a registered dietitian, medical writer and champion of a holistic approach to disease prevention.